First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    ABVC BioPharma, Inc.

    ABVC · 2 developments mapped · last assessed 2026-08-27

    Market Ontology has mapped 2 macro, policy, and market developments to ABVC BioPharma, Inc. since 2026-08-27. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for ABVC yet, so no modelled value is shown. The ABVC valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run ABVC on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for ABVC. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Open question

      ABVC BioPharma Announces Spin-Off of BioKey (Cayman), Inc.

      Direct corporate restructuring, asset divestiture, and potential re-rating of remaining business.

      · Moves future growth rates of remaining business, cost of capital (wacc) due to potential change in risk profile, terminal multiple reflecting focused operations

    What changed, by assumption

    Future growth rates of remaining business
    • 2026-08-27ABVC BioPharma Announces Spin-Off of BioKey (Cayman), Inc.
    • 2026-08-27ABVC BioPharma Completes Spin-off of BioKey (Cayman), Inc.

    Assumption changes

    Full ledger →
    DateAssumptionDirectionWhyConf.
    2026-08-12RevenueBearishSpun-off business revenue exits parent consolidated P&L.0.70
    2026-08-12Valuation multipleBullishSpin-off removes conglomerate discount on remaining parent.0.70

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-08-27ABVC BioPharma Announces Spin-Off of BioKey (Cayman), Inc.mixed3-12m0.70
    2026-08-27ABVC BioPharma Completes Spin-off of BioKey (Cayman), Inc.mixed1-3m0.70